Lates News

Swiss pharmaceutical company Roche stated that if US President Trump implements executive orders to reduce prescription drug costs, the company will need to reconsider its investment plans in the United States. Roche announced last month its plan to invest $50 billion in the pharmaceutical and diagnostic fields in the US over the next five years, creating over 12,000 job opportunities. Roche expects that the executive order will not have an impact on its business this year, but it believes that it will damage the US's position as a world leader in the pharmaceutical and healthcare ecosystem, stifle economic growth, and lead to unemployment.